Relay Therapeutics Inc. Common Stock vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.14 (market cap $3.82B), while Vanguard S&P 500 Growth Index Fund ETF trades at $87.14 (market cap $27.10B). The key difference: Vanguard S&P 500 Growth Index Fund ETF is far larger — about 7.1× Relay Therapeutics Inc. Common Stock's market cap, and Vanguard S&P 500 Growth Index Fund ETF is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Vanguard S&P 500 Growth Index Fund ETF for 54 Days on average.
| RLAY | VOOG | |
|---|---|---|
Market Cap | $3.82B | $27.10B |
Volume | 4,332,079 | 1,178,312 |
Sector | Health | Broad Market / Factor |
52-Week High | $20.75 | $87.81 |
52-Week Low | $6.03 | $65.32 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $2.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VOOG trades at $87.69, down slightly by 0.14% on the day, with technical indicators showing mixed signals—bullish moving averages but bearish oscillators including an overbought RSI. The ETF, tracking the S&P 500 Growth Index, has delivered strong long-term returns, with recent news highlighting institutional buying and outperformance versus peers. Key support sits at $87, resistance at $88.
Outlook remains positive for long-term growth investors given VOOG's low expense ratio and historical outperformance, though near-term risks include tech sector concentration and market volatility. The ETF's focus on large-cap growth stocks positions it well for sustained appreciation, but investors should be cautious of valuation extremes in growth segments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Read more on VOOG →